Drug targets and Drug Delivery
The expression "biological target" is mostly used as a part of pharmaceutical research to depict the native protein in the body whose movement is modified by a drug resulting in a particular impact, which might be an alluring therapeutic impact or an undesirable antagonistic impact. In this specific circumstance, the biological target is usually referred to as a Drug target. Distinguishing the biological origin of a disease, and the potential focuses for intervention, is the initial phase in the discovery of a drug utilizing the reverse pharmacology approach. Various diverse target discovery approaches have been recognized, for example, drug affinity responsive target stability (DARTS).
- Drug Interactions
- Ligand Based Drug Design
- Scoring functions
- Structure Based Drug Design
- Protein crystallography in drug discovery
- Molecular modeling in drug design
- Cancer drug design and discovery
- Drug design strategies
- Transformative concepts for drug design
Related Conference of Drug targets and Drug Delivery
Drug targets and Drug Delivery Conference Speakers
Recommended Sessions
- Biochemsitry and Biophysics
- Cellular and Molecular Biology
- Computational Approaches in Structural Biology
- Crystallography, NMR & Mass Spectrometry
- Determination of 3D structures
- Drug targets and Drug Delivery
- Gene Regulation and Cell Signaling
- Molecular Biology and Biomarkers
- Sequence Analysis
- Structural and Molecular Biology
- Structural Biology and Bioinformatics
- Structural Biology in Cancer Research
- Structural Enzymology
- Structural Genetics and Genomics
Related Journals
Are you interested in
- 3-D Structure Determination - Structural Biology 2025 (Germany)
- Advancements in structural Biology - Structural Biology 2025 (Germany)
- Biochemistry - Glycobiology 2025 (Germany)
- Biochemistry and Biophysics - Structural Biology 2025 (Germany)
- Computational Approach in Structural Biology - Structural Biology 2025 (Germany)
- Drug Designing and Biomarkers - Structural Biology 2025 (Germany)
- Evolution of Glycan Diversity - Glycobiology 2025 (Germany)
- Frontiers in Structural Biology - Structural Biology 2025 (Germany)
- Gene regulation and Cell Signalling - Structural Biology 2025 (Germany)
- Genomics and Metabolomics - Glycobiology 2025 (Germany)
- Glycans in Diseases and Therapeutics - Glycobiology 2025 (Germany)
- Glycans in Drug Design - Glycobiology 2025 (Germany)
- Glycan’s - Glycobiology 2025 (Germany)
- Glycobiology - Glycobiology 2025 (Germany)
- Glycochemistry - Glycobiology 2025 (Germany)
- Glycoimmunology - Glycobiology 2025 (Germany)
- Glycoinformatics - Glycobiology 2025 (Germany)
- Glycolipids and Glycopeptides - Glycobiology 2025 (Germany)
- Glyconeurobiology - Glycobiology 2025 (Germany)
- Glycopathology - Glycobiology 2025 (Germany)
- Glycosience - Glycobiology 2025 (Germany)
- Hybrid approaches in Structure prediction - Structural Biology 2025 (Germany)
- Molecular Biology - Structural Biology 2025 (Germany)
- Molecular biology techniques - Structural Biology 2025 (Germany)
- Molecular Modelling and Dynamics - Structural Biology 2025 (Germany)
- Proteoglycan and Sialic acid - Glycobiology 2025 (Germany)
- Proteomics and Genomics - Structural Biology 2025 (Germany)
- Recent Advances in Glycobiology - Glycobiology 2025 (Germany)
- Sequencing Analysis - Structural Biology 2025 (Germany)
- Structural Bioinformatics - Structural Biology 2025 (Germany)
- Structural Biology - Structural Biology 2025 (Germany)
- Structural Biology Databases - Structural Biology 2025 (Germany)
- Structural Biology in Cancer Research - Structural Biology 2025 (Germany)
- Structural Enzymology - Structural Biology 2025 (Germany)
- Synthesis and Biological Role of Glycans - Glycobiology 2025 (Germany)